XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED BALANCE SHEET - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
ASSETS    
Cash and cash equivalents $ 61,169 $ 58,166
Mortgage-backed securities, at fair value(1) [1] 1,218,306 1,081,380
Other investments, at fair value 309 292
Due from brokers 58,296 47,798
Financial derivatives–assets, at fair value 7,310 2,791
Reverse repurchase agreements 9,975 0
Receivable for securities sold 7,022 0
Interest receivable 3,786 4,114
Other assets 502 270
Total Assets 1,366,675 1,194,811
LIABILITIES    
Repurchase agreements 1,062,197 1,015,245
Payable for securities purchased 125,853 0
Due to brokers 577 1,064
Financial derivatives–liabilities, at fair value 3,090 6,630
U.S. Treasury securities sold short, at fair value 9,974 0
Dividend payable 3,881 3,456
Accrued expenses 1,207 918
Management fee payable to affiliate 598 626
Interest payable 398 470
Total Liabilities 1,207,775 1,028,409
SHAREHOLDERS' EQUITY    
Preferred shares, par value $0.01 per share, 100,000,000 shares authorized; (0 shares issued and outstanding, respectively) 0 0
Common shares, par value $0.01 per share, 500,000,000 shares authorized; (12,935,358 and 12,343,542 shares issued and outstanding, respectively) 129 123
Additional paid-in-capital 236,869 229,614
Accumulated deficit (78,098) (63,335)
Total Shareholders' Equity 158,900 166,402
Total Liabilities and Shareholders' Equity $ 1,366,675 $ 1,194,811
[1] Includes assets pledged as collateral to counterparties. See Note 6 for additional details on the Company's borrowings and related collateral.